Last reviewed · How we verify

NCT06857916

Cycle and Stroke With Biofeedback for Power Symmetry

Recruiting now NA Last updated 5 March 2025
What this trial tests

NA trial testing Traditional in Stroke in 20 participants. Currently enrolling.

Timeline
1 April 2021
Primary endpoint
14 November 2025
1 December 2025

Quick facts

Lead sponsorUniversity of Utah
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 April 2021
Primary completion14 November 2025
Estimated completion1 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Utah

Who can join

Adults 18 to 70, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine changes in power symmetry, gait symmetry, and functional outcomes for participants' poststroke (Inpatient Rehabilitation Facility) after participating in an intervention using a recumbent cycle with power biofeedback (BFB). To determine how this intervention can impact gait asymmetry, a common disorder poststroke secondary to hemiparesis. Gait asymmetry is a difficult impairment to treat because it is difficult for both therapists and patients to perceive. Training with BFB allows for quantitative data about the power production or lack of that directly impacts safety in walking, increased energy expenditure, and decreased gait speed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Traditional

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Utah trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06857916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing